Abdelkader Rahmaoui

1.1k citations
8 papers · 590 indexed · 1 hit paper · h-index 5
Topics
Asthma and respiratory diseases (4 papers)Respiratory and Cough-Related Research (2 papers)Pharmaceutical studies and practices (2 papers)

In The Last Decade

Abdelkader Rahmaoui

7 papers receiving 582 citations

Hit Papers

Efficacy and Safety of Omalizumab in Patients with Chroni...20142026201820222014100200300

Peers

Abdelkader Rahmaoui
Comparison fields: 5 of 35
  • Rheumatology 345
  • Physiology 277
  • Genetics 201
  • Pathology and Forensic Medicine 193
  • Immunology and Allergy 158
Replace Mary S. Bradley with:
Mary S. Bradley United States
Nikhil Kamath United Kingdom
Jorge Alfonso Ross Terres United States
H Pellet France
Barbara Sokołowska Poland
M G Ridley United Kingdom
Paolo Delvino Italy
B Hamrin Sweden
R Silver United States
Brunella Valzorio Italy
Abdelkader Rahmaoui relative to Mary S. Bradley United States Mary S. Bradley's profile →
Citations per field
00.5×1.5×
Mary S. Bradley · 1×
Citations per year

Countries citing papers authored by Abdelkader Rahmaoui

Since Specialization
Citations

This map shows the geographic impact of Abdelkader Rahmaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdelkader Rahmaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdelkader Rahmaoui more than expected).

Fields of papers citing papers by Abdelkader Rahmaoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdelkader Rahmaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdelkader Rahmaoui. The network helps show where Abdelkader Rahmaoui may publish in the future.

Co-authorship network of co-authors of Abdelkader Rahmaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Abdelkader Rahmaoui. A scholar is included among the top collaborators of Abdelkader Rahmaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdelkader Rahmaoui. Abdelkader Rahmaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 2
2 7
3 80
4 150
5
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Studybreakdown →
307
6 0
7
Omalizumab and malignancy: Interim results from the EXCELS study
4
8 40

About Abdelkader Rahmaoui

Abdelkader Rahmaoui is a scholar working on Immunology and Allergy, Physiology and Pediatrics, Perinatology and Child Health, having authored 8 papers that have together received 590 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Respiratory and Cough-Related Research (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Immunology and Allergy (158 citations), Rheumatology (345 citations) and Genetics (201 citations). Abdelkader Rahmaoui has collaborated with scholars based in United States, Germany and Türkiye. Frequent co-authors include Mary S. Bradley, Karin Rosén, Emel Bülbül Başkan, Jean‐Jacques Grob, Oral Alpan, Sarbjit S. Saini, Janice Canvin, Sheldon L. Spector, Panayiotis Georgiou and Carsten Bindslev‐Jensen. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Journal of Investigative Dermatology and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026